Diagnostic performance of 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a systematic review and meta-analysis

[1]  D A Bloch,et al.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. , 2010, Arthritis and rheumatism.

[2]  Byron C. Wallace,et al.  Meta-Analyst: software for meta-analysis of binary, continuous and diagnostic data , 2009, BMC medical research methodology.

[3]  P. Cluzel,et al.  Is (18)F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? , 2009, Arthritis and rheumatism.

[4]  T. Bley,et al.  Imaging for large-vessel vasculitis , 2009, Current opinion in rheumatology.

[5]  G. Hunder,et al.  Polymyalgia rheumatica and giant-cell arteritis , 2008, The Lancet.

[6]  A. Heinzel,et al.  Assessment of Large-Vessel Involvement in Giant Cell Arteritis with 18F-FDG PET: Introducing an ROC-Analysis–Based Cutoff Ratio , 2008, Journal of Nuclear Medicine.

[7]  M. Cimmino,et al.  Is FDG-PET useful in the evaluation of steroid-resistant PMR patients? , 2008, Rheumatology.

[8]  L. Kanz,et al.  [18F] FDG-PET/CT as a new and sensitive imaging method for the diagnosis of large vessel vasculitis. , 2008, Clinical and experimental rheumatology.

[9]  M. Heller,et al.  MRI and FDG-PET in the assessment of inflammatory aortic arch syndrome in complicated courses of giant cell arteritis , 2008, Annals of the rheumatic diseases.

[10]  Johannes B Reitsma,et al.  Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies , 2006, BMC medical research methodology.

[11]  L. Mortelmans,et al.  Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. , 2006, Arthritis and rheumatism.

[12]  L. Mortelmans,et al.  Repetitive 18-fluorodeoxyglucose positron emission tomography in isolated polymyalgia rheumatica: a prospective study in 35 patients. , 2005, Rheumatology.

[13]  D. Consonni,et al.  Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. , 2005, Arthritis and rheumatism.

[14]  J. Nolla,et al.  Giant cell arteritis and polymyalgia rheumatica: usefulness of vascular magnetic resonance imaging studies in the diagnosis of aortitis. , 2005, Rheumatology.

[15]  Christian Schindler,et al.  The value of [18F]FDG-PET in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease , 2005, European Journal of Nuclear Medicine and Molecular Imaging.

[16]  John Ioannidis,et al.  Meta-Analysis: Test Performance of Ultrasonography for Giant-Cell Arteritis , 2005, Annals of Internal Medicine.

[17]  Ora Israel,et al.  Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  F. Strutz,et al.  Diagnosis and follow up of aortitis in the elderly , 2004, Annals of the rheumatic diseases.

[19]  E. Henze,et al.  Correlation between 18-fluorodeoxyglucose accumulation in large vessels and serological markers of inflammation in polymyalgia rheumatica: a quantitative PET study , 2004, Annals of the rheumatic diseases.

[20]  M. González‐Gay,et al.  Giant cell arteritis and polymyalgia rheumatica: two different but often overlapping conditions. , 2004, Seminars in arthritis and rheumatism.

[21]  G. Hunder,et al.  Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. , 2003, Arthritis and rheumatism.

[22]  P. Bossuyt,et al.  BMC Medical Research Methodology , 2002 .

[23]  W. Oyen,et al.  F-18-fluorodeoxyglucose positron emission tomography in diagnosis and follow-up of patients with different types of vasculitis. , 2003, The Netherlands journal of medicine.

[24]  M. Brodmann,et al.  The role of 2-18F-fluoro-2-deoxy-D-glucose positron emission tomography in the diagnosis of giant cell arteritis of the temporal arteries. , 2003, Rheumatology.

[25]  C. Weyand,et al.  Giant-Cell Arteritis and Polymyalgia Rheumatica , 2003, Annals of Internal Medicine.

[26]  L. Mortelmans,et al.  Imaging of large vessel vasculitis with 18FDG PET: illusion or reality? A critical review of the literature data , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  F. Strutz,et al.  Early diagnosis and follow-up of aortitis with [18F]FDG PET and MRI , 2003, European Journal of Nuclear Medicine and Molecular Imaging.

[28]  M. González-Gay,et al.  Biopsy-negative giant cell arteritis: clinical spectrum and predictive factors for positive temporal artery biopsy. , 2001, Seminars in arthritis and rheumatism.

[29]  A. Hajeer,et al.  Visual Manifestations of Giant Cell Arteritis: Trends and Clinical Spectrum in 161 Patients , 2000, Medicine.

[30]  M. Cimmino,et al.  Epidemiology of polymyalgia rheumatica. , 2000, Clinical and experimental rheumatology.

[31]  A. Maes,et al.  Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. , 2000, The American journal of medicine.

[32]  J. Nuyts,et al.  New arguments for a vasculitic nature of polymyalgia rheumatica using positron emission tomography. , 1999, Rheumatology.

[33]  G. Hoffman,et al.  Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from The International Network for the Study of the Systemic Vasculitides (INSSYS). , 1998, International journal of cardiology.

[34]  S. Gabriel,et al.  The Incidence of Giant Cell Arteritis in Olmsted County, Minnesota: Apparent Fluctuations in a Cyclic Pattern , 1995, Annals of Internal Medicine.

[35]  G. Hunder,et al.  Increased Incidence of Aortic Aneurysm and Dissection in Giant Cell (Temporal) Arteritis: A Population-Based Study , 1995, Annals of Internal Medicine.

[36]  B. Bengtsson,et al.  Epidemiology and mortality in 220 patients with polymyalgia rheumatica. , 1995, British journal of rheumatology.

[37]  S. Gabriel,et al.  Epidemiology of polymyalgia rheumatica in Olmsted County, Minnesota, 1970-1991. , 1995, Arthritis and rheumatism.

[38]  S. Leeder,et al.  A population based study , 1993, The Medical journal of Australia.

[39]  G. Hunder,et al.  Visual prognosis in giant cell arteritis. , 1993, Ophthalmology.

[40]  S. Sutinen,et al.  Giant cell arteritis and polymyalgia rheumatica in a region of Finland: an epidemiologic, clinical and pathologic study, 1984-1988. , 1992, The Journal of rheumatology.

[41]  C. Salvarani,et al.  Epidemiologic and immunogenetic aspects of polymyalgia rheumatica and giant cell arteritis in northern Italy. , 1991, Arthritis and rheumatism.

[42]  P. Boesen,et al.  Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985. , 1987, Arthritis and rheumatism.

[43]  A. Roth,et al.  The ultimate diagnoses of patients undergoing temporal artery biopsies. , 1984, Archives of ophthalmology.

[44]  L. A. Healey.  Long-term follow-up of polymyalgia rheumatica: evidence for synovitis. , 1984, Seminars in arthritis and rheumatism.

[45]  G. Hunder,et al.  THE THERAPEUTIC IMPACT OF TEMPORAL ARTERY BIOPSY , 1983, The Lancet.

[46]  G. Hunder,et al.  Giant cell arteritis (temporal arteritis) presenting as fever of undetermined origin. , 1981, Arthritis and rheumatism.

[47]  W. Hauser,et al.  Temporal arteritis in Rochester, Minnesota, 1951 to 1967. , 1971, Mayo Clinic proceedings.

[48]  Walker Jc.  NEW GENERAL-PURPOSE HOSPITAL BED. , 1964 .

[49]  J. Hutchinson.  II. On a Peculiar Form of Fibrous Tumor, which Tends to Multiplicity and Indefinite Growth. , 1885, Annals of Surgery.

[50]  J. Marienhagen,et al.  18F-FDG PET as a diagnostic procedure in large vessel vasculitis—a controlled, blinded re-examination of routine PET scans , 2010, Clinical Rheumatology.

[51]  Andreas Krause,et al.  Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. , 2008, Rheumatology.

[52]  A. Gibofsky.  American College of Rheumatology. , 2002, Journal of the Medical Association of Georgia.

[53]  P. Elling,et al.  Synchronous variations of the incidence of temporal arteritis and polymyalgia rheumatica in different regions of Denmark; association with epidemics of Mycoplasma pneumoniae infection. , 1996, The Journal of rheumatology.

[54]  Guy Hoffman,et al.  Takayasu Arteritis , 1994, Annals of Internal Medicine.

[55]  P. Boesen,et al.  Giant cell arteritis, temporal arteritis, and polymyalgia rheumatica in a Danish county. A prospective investigation, 1982-1985. , 1987, Arthritis and rheumatism.

[56]  G. Ostberg.  An arteritis with special reference to polymyalgia arteritica. , 1973, Acta pathologica et microbiologica Scandinavica. Supplement.

[57]  V. Ritama.  Temporal arteritis. , 1951, Annales medicinae internae Fenniae.